Loading

Annals of Clinical Pathology

Role of Toll-Like Receptor2 (TLR 2) Genetic Polymorphisms in Modulating Susceptibility to Clinical Disease in Wuchereria Bancrofti

Research Article | Open Access

  • 1. National Institute for Medical Research, Sokoine University of Agriculture, Tanzania
  • 2. Sokoine University of Agriculture, Tanzania
+ Show More - Show Less
Corresponding Authors
Happyness J. Mshana, National Institute for Medical Research, Sokoine University of Agriculture, Tanga centre, P.O. Box 5004, Tanzania, Tel: 255-653-864862
Abstract

Background: Bancroftian filariasis a parasitic vector-borne disease among the communicable neglected tropical infectious disease. The disease has been found to compromise the well-being of large populations in endemic countries within the tropics and sub-tropics. Despite of the several studies attempted to document on the mechanism involved in the development of clinical disease, until now the pathogenesis of the disease is not yet clear to date, although there, several underlined aetiological factors being implicated. This study was conducted to determine the role of TLR 2 –196 to –173 del and its association with asymptomatic bancroftian filariasis in endemic communities of Tanga region in north eastern Tanzania.

Methods: TLR 2 -196 to -173 polymorphism in the 5’ untranslated region using allele specific real time -polymerase chain reaction (RT-PCR) were tested in 79 individuals.

Results: TLR 2 -196 to – 173 polymorphisms were tested positive in 36.7 % of the samples.

Conclusion: TLR 2 -196 to -173 del polymorphisms occurrence among individuals infected with bancroftian filariasis disease highlights the potential for the susceptibility of bancroftian filariasis infection and importance of further genetic research for better understanding the mechanism of infection transmission and heterogeneity of the disease.

Citation

Mshana HJ, Ngowi SX, Baraka V, Misinzo G, Makunde WH (2020) Role of Toll-Like Receptor 2 (TLR 2) Genetic Polymorphisms in Modulating Susceptibility to Clinical Disease in Wuchereria Bancrofti. Ann Clin Pathol 7(1): 1151.

Keywords

•    Toll-Like Receptor 2 (TLR 2)
•    Lymphatic filariasis
•    Wuchereria bancrofti

INTRODUCTION

Lymphatic filariasis is a mosquito-borne among the communicable neglected tropical infectious disease. The disease has been found to compromise the well being a large population in endemic countries within the tropics. During the early stage of the clinical progression, the disease presents with acute febrile conditions involving the inguinal lymph nodes where adults’ filarial worms dwell and this can lead to adenolymphangitis (ADL) which progresses distally, a typical for Wuchereria bancrofti. These immune responses such as; pro-inflammatory cytokines, including IL-1Beta and TNF-alfa have been shown to upregulate the expression of VEGF-C, raising the possibility that pro-inflammatory cytokines affect the lymphatic vessels via VEGF-C [1]. Therefore, pro-inflammatory cytokines are able stimulate proliferation of lymphatic endothelia [2] and are elevated in lymph from parasitized lymphatics. If the ADL are secondarily affected by local skin bacteria or fungal infection the condition will be more broad hence adeno-dermatolymphangitis (ADDL). Individuals harbouring adult filarial worm in the lymphatics of the scrotal area will trigger inflammation in pertunica vaginalis causing acute orchitis which will progess into chronic and eventually small hydrocele if not treated. This is now a clinical hydrocoele a condition that can be clinically diagnosed and surgically managed. The other clinical condition caused by the wuchereria bancrofti is the lymphoedema of lower limbs and upper. Although there two clinical condition emanating from one disease the pathogenesis of each one is different and unclear until to date, although there several underlined aetiological factors being implicated. For the condition to occur, some conditions have to be present, these includes; the mosquito- vectors, the infective larvae (L3), human host, the filarial nematode host of the wolbachia and the wolbachia endosymbionts bacteria. The disease has two clinical spectrum of presentation, one end with those amicrofilareamic and down-regulated through cellmediated responses and having pathologies, whereas the other extreme are those microfilaraemics without pathologies

The immune responses differ between individuals who present pathologies and those who don’t. One plausible explanation for the different responses is that, single-nucleotide polymorphisms (SNPs) alter the expression of or the activity of immune factors such as; MHC gene products, human host-wolbachia molecules (LPS-LBP-TLR 4)-mcD14-ScD14 and cytokines] leading to the broad range of clinical-disease manifestations that are observed. On the other hand, the presence of adult filarial worms in the lymphatic vessels and lymph nodes is also a factor known to trigger the pathology [3]. Those worms in the vessels they alter the structural anatomy of the vessels leading to massive accumulation of lymph fluid resulting into lymphoedema and irreversible obstructive lesions within the vessels and their walls.

Toll-like receptors (TLRs) are pattern-recognition receptors (PRRs), that recognize evolutionarily conserved structures on the invading pathogens [4]. TLRs trigger a number of pro inflammatory and anti-microbial responses, through ligands binding for defence against the pathogens and promoting adaptive immunity responses. TLR 4 is the signal transducing element of the lipopolysaccharide (LPS) receptor complex1 and is also involved in the signalling response to other exogenous stimuli [4]. TLR 5 binds flagellin, a bacterial protein involved in motility and TLR 9 recognizes CpG, a repetitive sequence of unmethylated nucleic acids (guanine and cytosine) [4]. Growing amounts of data suggest that single nucleotide polymorphisms (SNPs) on the various human TLR proteins are associated with altered susceptibility to infection. TLR-2, as a heterodimer with TLR-1 or TLR-6, two synonymous SNPs on TLR 2 gene have been associated with asymptomatic bancroftian filariasis [5]. A-196 to -173 deletions polymorphisms in the 5’ untranslated region of TLR2 gene and two synonymous SNPs, 597C>T (rs3804099, Asn199ASN) and 1350C>T (rs3804100, Ser450Ser) in exon 3 are associated with asymptomatic bancroftian filariasis [5]. However other studies have indicated that TLR 2 polymorphisms do not correlate with lymphatic filariasis infection status or disease phenotype of lymphatic filariasis [6]. Since there is limited data regarding TLR 2 mutations, additional genotyping studies on TLR 2 and other candidate genes involved in susceptibility to lymphatic filariasis will be required to determine their contribution to the heterogeneous pattern of infection and filarial disease. Therefore, the aim of this objective is to determine the role of deletion polymorphisms in TLR 2 gene and their potential association to filarial infection. Exploring the role of the TLR 2 polymorphisms is important to the understanding of the pathogenesis and protection against filarial infection.

MATERIALS AND METHODS

Study site

Tanga region lies between longitude of 35 E and latitude of 2.75. It consists of different ethnic groups and large minority being Wazigua. The livestock species kept are primarily cattle, goats, sheep and donkey. The area has two rainy seasons: the short rainy season and the long rain season with annual precipitation between 500 and 1,000mm. The study was carried out in five villages of Tanga District located in North eastern Tanzania an area known to be endemic for bancroftian filariasis. The villages included Tanga city, Pangani, Muheza and Mkinga.

Study design

The study involved the samples collected from previously cross sectional survey conducted in September 2016 in the study villages (Figure 1). Samples were collected from lymphatic filariasis (lymphoedema, hydrocele, CFA positives, 18-74 years old) patients resides in endemic communities of Tanga region.

Blood collection

A total of 10 mls of EDTA monovette of blood were collected from each volunteer; plasma was separated and stored at -80°C. The blood pellets were mixed 1:1 with 8M Urea and transport to laboratory.

DNA extraction

Genomic DNA was extracted from peripheral blood preserved in an equal volume of 8M urea from the patients using the QIAmp? kit from Qiagen (Hilden, Germany ) as instructed by the manufacturer.

Plasmids preparation.

E. coli bacteria were grown on 15 mls of Lysogen Broth medium with appropriate temperature of 37°C overnight. Lysogen Broth medium allows bacteria that have been successful transformed to grow uninhibited. Overnight culture was then transferred to 1.5 mls Eppendorf tube and spin down the cell culture at high speed for 1 minute, 250 mls of lysis buffer solution were added and mix gently by inverting the tube 6-8 times followed by 250 mls of neutralizing buffer solution. Bacteria precipitates were observed around the tube. Centrifugation were done at 13000 rpm for 10 minutes then the supernatant was transferred to 1.5 mls Eppendorf tube and plasmid DNA pellets were resuspended by TE buffer.

DNA concentration measurements

The concentration of DNA was measured using the spectrophotometer by measuring the absorbance at 260 nm where DNA absorbs light mostly strong and the number generated allowed to estimate the concentration of the solution. The copy number of the standard were calculated using the following mathematical correlation formulas as a guideline

For average molecular weight of Calculation
ds DNA (number of base pairs) x (660 daltons/base pairs)
ss DNA (number of base pairs) x (330 daltons/base pairs)
ss RNA (number of base pairs) x (340 daltons/base pairs)

MW=Molecular weight (g/mol)
1mol=6x10^23 molecules (=copies)

6x10^23 (copies/mol) x concentration (g/mol) = amount (copies/µl)

MW(g/mol)

Real time Polymerase chain reaction

The molecular detection of the of the TLR 2 -196 to -173 del polymorphism was performed using the RT-Polymerase chain reaction system (Rotor gene 6000 Real Time PCR system). The primers used were, TLR – 2 Forward: (5’- cgg agg cag cga gaa a-3’) and TLR – 2 Reverse: (5’- ctg ggc cgt gca aag aag-3’) and the TaqMan deletion probe (5’-agc cag gtg act gc- 3’) and wild type probe (5’- acg ccg agc agc cg-3’) targeting 23 base pair fragment of the TLR 2 In/del. The results of the assay were assessed by the Ct value.

Polymerase chain reaction parameters

The polymerase chain reaction (PCR) was carried as follows. The 20 µl reaction mixture contained 2 µl of 50 ng of template DNA, 10 µl of Quantinova master mix, 0.6 µl of forward and reverse primer respectively, 0.2 µl of wild type probe and deletion probe respectively, 6.6 µl of deionized water. The amplification was carried out using the Rotor gene 6000 Real Time PCR system. The amplification profile consisted of: 95°C for 2 minutes; followed by 45 cycles of 95 °C for 5 seconds and 58°C for 30 seconds. The amplification of all DNA samples was repeated three times in order to see variability, if any in the amplification pattern.

Statistical analysis

FamHap software was used to carry the statistical analysis. The goodness of fit to Hardy–Weinberg Equilibrium (HWE) was performed using a chi-square (χ2) test. Determination of allele and genotype were determined by direct counting and then divided by the number of chromosomes to produce an allele frequency or by the number of subjects to produce the genotype frequency. Allele or genotype frequencies were compared between bancroftian filariasis patients, lymphedema, hydrocele and normal controls to ascertain the association. P-values were considered significant at ≤ 0.05.

RESULTS

The molecular detection by real time PCR indicated that 36.7 % of the samples were positive for TLR 2 -196 to – 173 del genotype Figure 2.

polymorphisms Lymphoedema (n=26) Hydrocele ( n=28 ) Genotypic model OR P-Armitage value
−196 to −173 del          
wt/wt 17 16 0.561 0.818 0.622
wt/del 0 1      
del/del 9 11      

 

DISCUSSION

This study has demonstrated the evidence of TLR 2 -196 to -173 polymorphism in the 5’ untranslated region in individuals reside in the endemic communities of Tanga region, North Eastern Tanzania. The study was carried 14 years after the implementation of the mass drug administration using the drug combination of ivermectin and albendazole with the aim of interrupting the bancroftian filariasis infection. During the course of the study, the cross sectional survey findings demonstrated a considerable reduction in filarial infection [8].

The TLR 2 haplotype -196 to -173 del/ +597C/+1350C have been reported to strongly associated with an increased risk of asymptomatic bancroftian filariasis in Thailand [9]. No previous reports of association have been reported in the area. A case control study conduted in Ghana revealed the strong association of TLR 2 -196 to -173 del with asymptomatic bancroftian filariasis. (jubin et al., 2017 unpublished data). However, the same investigation could not detect the association in individual tested in Tanga region. Due to limited resources only a subset of positive samples was subjected to RT-PCR analysis and this is considered to be limitation of this study. Other studies have demonstrated the role of polymorphisms in various host genes and susceptibility and clinical manifestation of lymphatic filariasis such as Vascular Endothelial Growth Factors and Mannose-binding lectin [9]. However little is known regarding the pathogenesis of the disease and this calls for more research in the area for better understanding of the disease, considering the fact that there are potential mosquito vectors in the area, the risk of disease emergence is still high.

CONCLUSION

TLR 2 -196 to -173 del occurrence among individuals infected with bancroftian filariasis disease highlights the importance of further research for better understanding the mechanism of infection transmission and heterogeneity of the disease.

ACKNOWLEDGMENT

The authors are grateful to the villagers in Tanga region for their dedicated cooperation, to the technical staff from NIMR-Tanga (Fides Mumburi, Xavaeli Ngowi, Charles Guzo and Salim Tembo) for their assistance in the field and the laboratory. Funding: The study received financial support from University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology (Grant code PF 673/2-1).

Table 1: Genotype frequencies of TLR2 -196 to – 173 del in Lymphedema and Hydrocele.

Polymorphisms bancroftian filariasis patients ( n=6 ) Lymphoedema (n=26) Genotypic model OR P-Armitage value
−196 to −173 del          
wt/wt 4 17 0.998 0.944 0.952
wt/del 0 0      
del/del 2 9      

Table 2: Genotype frequencies of TLR2 -196 to – 173 del in bancroftian filariasis patients and Lymphedema.

Polymorphisms Bancroftian
filariasis
patients
Normal
controls
Genotypic model OR P-Armitage value
−196 to −173 del          
wt/wt 4 9 0.907 0.643 0.658
wt/del 0 0      
del/del 2 7      

Table 3: Genotype frequencies of TLR 2 -196 to – 173 del in bancroftian filariasis patients and endemic normal.

Polymorphisms Bancroftian
filariasis
patients
Hydrocele Genotypic model OR P-Armitage value
−196 to −173 del          
wt/wt 4 16 0.845 0.773 0.721
wt/del 0 1      
del/del 2 00      

Table 4: Genotype frequencies of TLR2 -196 to – 173 del in bancroftian filariasis patients andhydrocele.

Polymorphisms Lymphoedema (n=26) Hydrocele ( n=28 ) Genotypic model OR P-Armitage value
−196 to −173 del          
wt/wt 17 16 0.561 1.202 0.622
wt/del 0 1      
del/del 9 11      

Table 5: Genotype frequencies of TLR2 -196 to – 173 del in Lymphoedema andhydrocele.

Polymorphisms Endemic normal ( n=16 ) Lymphoedema (n=26) Genotypic model OR (95%CI) P-Armitage value
−196 to −173 del          
wt/wt 9 17 0.839 1.469 0.554
wt/del 0 0      
del/del 7 9      

 

REFERENCES

1. Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K. “Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem. 1998; 273: 8413– 8418.

2. Rao UR, Zometa CS, Vickery AC, Kwa BH, Nayar JK, Sutton ET. “Effect of Brugia malayi on the growth and proliferation of endothelial cells in vitro. J Parasitol. 1996; 82: 550–556.

3. Pfarr KM, Debrah AY, Specht S, Hoerauf A. “Filariasis and lymphoedema. Parasite Immunology. 2009; 31: 664–672.

4. Hise A, Hazlett F, Bockarie M, Zimmerman P, Tisch D, Kazura J. “Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun. 2003.

5. Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG. “Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol. 2015.

6. Trejo-De La OA, Hernández-Sancén P, Maldonado-Bernal C. “Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer. Genes Immun. 2014; 15: 199- 209.

7. Batsa L. “Anti-Wolbachia Treatment of Lymphatic Filariasis and Genetic Analysis of the Pathology of Lymphedema as a Clinical Manifestation of the Disease. 2012.

8. Shana HJ, Baraka V, Misinzo G, Makunde WH. “Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region , Northeastern Tanzania. J Trop Med. 2016; 1–6.

9. Nuchprayoon S, Junpee A, Poovorawan Y. “Random Amplified Polymorphic DNA (RAPD) for differentiation between Thai and Myanmar strains of Wuchereria bancrofti. Filaria J. 2007; 6: 6.

Received : 28 Jan 2020
Accepted : 18 Feb 2020
Published : 20 Feb 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X